Nkarta, Inc.

( )
NKTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.80%69.520.0%$2233.03m
NVAXNovavax, Inc. -16.77%124.4299.2%$975.55m
SRNESorrento Therapeutics, Inc. -11.92%12.411.5%$660.63m
GILDGilead Sciences, Inc. 1.09%68.841.0%$572.71m
AMGNAmgen, Inc. 3.01%241.721.3%$487.38m
REGNRegeneron Pharmaceuticals, Inc. 2.25%612.352.7%$403.88m
VRTXVertex Pharmaceuticals, Inc. 3.43%270.851.9%$372.31m
BNTXBioNTech SE 0.96%69.110.0%$367.35m
BIIBBiogen, Inc. 1.13%293.221.6%$358.10m
ILMNIllumina, Inc. 0.86%344.143.5%$335.56m
VXRTVaxart, Inc. -14.42%9.200.0%$307.65m
ATNMActinium Pharmaceuticals, Inc. -0.31%9.6313.3%$235.99m
EBSEmergent BioSolutions, Inc. 6.00%129.676.4%$186.47m
ALXNAlexion Pharmaceuticals, Inc. 1.52%102.782.0%$167.42m
SGENSeattle Genetics, Inc. 3.46%158.796.2%$160.84m

Company Profile

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.